304 related articles for article (PubMed ID: 18321891)
1. Survival of metastatic germ cell cancer patients assessed by international germ cell consensus classification in Japan.
Shintaku I; Satoh M; Okajima E; Fujimoto H; Kamoto T; Ogawa O; Kawai K; Akaza H; Tsukamoto T; Naito S; Miki T; Arai Y
Jpn J Clin Oncol; 2008 Apr; 38(4):281-7. PubMed ID: 18321891
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
Kawai K; Hinotsu S; Oikawa T; Sekido N; Hattori K; Miyanaga N; Hasegawa Y; Kojima H; Shimazui T; Akaza H
Jpn J Clin Oncol; 2006 Nov; 36(11):723-30. PubMed ID: 17082218
[TBL] [Abstract][Full Text] [Related]
3. Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis.
van Dijk MR; Steyerberg EW; Habbema JD
Eur J Cancer; 2006 May; 42(7):820-6. PubMed ID: 16574403
[TBL] [Abstract][Full Text] [Related]
4. Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.
Sonneveld DJ; Hoekstra HJ; van der Graaf WT; Sluiter WJ; Mulder NH; Willemse PH; Koops HS; Sleijfer DT
Cancer; 2001 Apr; 91(7):1304-15. PubMed ID: 11283931
[TBL] [Abstract][Full Text] [Related]
5. Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration.
Kildahl-Andersen A; Erke MG; Sagstuen H; Bremnes RM
Acta Oncol; 2005; 44(6):537-44. PubMed ID: 16165912
[TBL] [Abstract][Full Text] [Related]
6. Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors: a multiinstitutional retrospective analysis of 41 patients.
Ogawa K; Toita T; Nakamura K; Uno T; Onishi H; Itami J; Shikama N; Saeki N; Yoshii Y; Murayama S
Cancer; 2003 Jul; 98(2):369-76. PubMed ID: 12872359
[TBL] [Abstract][Full Text] [Related]
7. Germ cell tumours of the testis: clinical features, treatment outcome and prognostic factors.
Bhutani M; Kumar L; Seth A; Thulkar S; Vijayaraghavan M; Kochupillai V
Natl Med J India; 2002; 15(1):18-21. PubMed ID: 11855586
[TBL] [Abstract][Full Text] [Related]
8. Primary germ cell tumors in the mediastinum: a 50-year experience at a single Japanese institution.
Takeda S; Miyoshi S; Ohta M; Minami M; Masaoka A; Matsuda H
Cancer; 2003 Jan; 97(2):367-76. PubMed ID: 12518361
[TBL] [Abstract][Full Text] [Related]
9. Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor.
Kojima T; Kawai K; Tsuchiya K; Abe T; Shinohara N; Tanaka T; Masumori N; Yamada S; Arai Y; Narita S; Tsuchiya N; Habuchi T; Nishiyama H
Int J Urol; 2015 Oct; 22(10):923-7. PubMed ID: 26094715
[TBL] [Abstract][Full Text] [Related]
10. Optimal treatment strategy for intracranial germ cell tumors: a single institution analysis.
Kanamori M; Kumabe T; Saito R; Yamashita Y; Sonoda Y; Ariga H; Takai Y; Tominaga T
J Neurosurg Pediatr; 2009 Dec; 4(6):506-14. PubMed ID: 19951035
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
[TBL] [Abstract][Full Text] [Related]
12. Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning.
van Dijk MR; Steyerberg EW; Stenning SP; Dusseldorp E; Habbema JD
Br J Cancer; 2004 Mar; 90(6):1176-83. PubMed ID: 15026798
[TBL] [Abstract][Full Text] [Related]
13. [Grading system for diagnosis and treatment of intracranial nongerminomatous malignant germ cell tumors].
Huang X; Zhang R; Zhou LF
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(33):2333-6. PubMed ID: 20095355
[TBL] [Abstract][Full Text] [Related]
14. Brain metastases from testicular germ cell tumors: a retrospective analysis.
Nonomura N; Nagahara A; Oka D; Mukai M; Nakai Y; Nakayama M; Nishimura K; Kakimoto K; Nakamura T; Usami M; Okuyama A; Miki T
Int J Urol; 2009 Nov; 16(11):887-93. PubMed ID: 19863625
[TBL] [Abstract][Full Text] [Related]
15. The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
Marwaha S; Venner PM; North SA
Can J Urol; 2007 Oct; 14(5):3692-6. PubMed ID: 17949524
[TBL] [Abstract][Full Text] [Related]
16. Bilateral testicular germ cell tumors in Turkey: increase in incidence in last decade and evaluation of risk factors in 30 patients.
Akdogan B; Divrik RT; Tombul T; Yazici S; Tasar C; Zorlu F; Ozen H
J Urol; 2007 Jul; 178(1):129-33; discussion 133. PubMed ID: 17499297
[TBL] [Abstract][Full Text] [Related]
17. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
[TBL] [Abstract][Full Text] [Related]
18. Germ-cell tumors of the mediastinum.
Weidner N
Semin Diagn Pathol; 1999 Feb; 16(1):42-50. PubMed ID: 10355653
[TBL] [Abstract][Full Text] [Related]
19. [Primary mediastinal germ cell tumors].
Yoshitake T
Kyobu Geka; 1990 Jul; 43(7):582-92. PubMed ID: 2168496
[TBL] [Abstract][Full Text] [Related]
20. TCL1 is a diagnostic marker for intratubular germ cell neoplasia and classic seminoma.
Cao D; Lane Z; Allan RW; Wang P; Guo CC; Peng Y; Li J
Histopathology; 2010 Jul; 57(1):152-7. PubMed ID: 20553335
[No Abstract] [Full Text] [Related]
[Next] [New Search]